Novartis Breast Cancer Drug OK&#39;d for Wider US Use
559488
Novartis AG won US approval to promote the drug Femara for women who have finished standard therapy for early-stage breast cancer and run out of options, the company said on Friday.
673366
Swiss pharmaceutical maker Novartis AG said yesterday it has received US approval for the hypertension drug Tekturna -- a potential blockbuster that has shown the ability to lower blood pressure more effectively than common treatments.
728865
Novartis AG said on Wednesday that its  breast cancer pill Femara is more effective than the current  standard treatment tamoxifen in reducing the risk that the  cancer will return to older women after surgery.
40663
SAN ANTONIO -- Doctors say a newer class of drugs is showing better results in preventing the return of breast cancer than the more traditional drug, tamoxifen.
410925
An experimental treatment for brain cancer has won approval for commercial use in Switzerland, its London-listed US maker, Northwest Biotherapeutics, Inc., announced on Monday.
156055
TUESDAY, Feb. 13 (HealthDay News) -- Switching to newer breast cancer drugs, called aromatase inhibitors, after two to three years of treatment with tamoxifen may extend disease-free survival and slightly reduce the risk of death in women who've been treated for early stage disease, an international study finds.
186568
Pharmaceutical group Novartis said on Monday it had received U.S. approval for Exelon Patch, which delivers a treatment for Alzheimer's disease through a skin patch instead of an oral capsule.
432809
Pharmaceutical group Novartis on Monday  said it had received U.S. approval for Exelon Patch, which  delivers a treatment for Alzheimer&#39;s disease through a skin  patch instead of an oral capsule.
157177
WASHINGTON The Food and Drug Administration has agreed to allow broader application of a breast cancer drug. The drug (letrozole) is currently used against advanced breast cancer and the FDA will now allow
562146
In women who&#39;ve been treated for breast cancer, use of the drug tamoxifen can help prevent recurrence of the disease. Now, new research indicates that the
165412
Enablex, also known as darifenacin, was approved by the Food and Drug Administration. Novartis (nyse: NVS - news - people ) had purchased the drug from Pfizer (nyse: PFE - news - people ) for $225 million
117223
The Swiss drug giant Roche said it had won approval in Switzerland for a new cancer drug Avastin and hoped to get the go-ahead in over 90 other countries, including the European Union, soon.
749459
A new type of breast cancer drug is clearly superior to the old standard, tamoxifen, in many women and should now be the first drug used to treat the cancer, U.S. and British researchers said on Wednesday.
368066
The US drug agency agreed to allow a drug currently used against advanced breast cancer to be prescribed to prevent the disease from recurring in women who have been treated for early forms of the disease.
105288
WASHINGTON -- The Food and Drug Administration yesterday approved a cancer drug made by pharmaceutical giant Eli Lilly and Co. to treat advanced non-small cell lung cancer in patients who have undergone chemotherapy.
115886
Swiss drugmaker Novartis AG has informed doctors in Europe of new restrictions on prescribing lumiracoxib, its COX-2 inhibitor sold under the trade name Prexige, including regular liver monitoring, Britain's drug regulator said.
542334
Galvus, a diabetes drug produced by Novartis, has received a positive opinion from European health authorities after the firm made changes to prescribing recommendations due to liver safety issues.